K Pharma,Inc.
Code | Sector | Market |
---|---|---|
4896 | Pharmaceuticals | Growth |
Date of listing approval | 2023/09/12 |
---|---|
Expected Date | 2023/10/17 |
Lead Underwriter | SBI SECURITIES Co.,Ltd. |
Description |
Listed Shares(total) | 1,932,000 |
---|---|
Trading Unit | 100 |
New Shares | 1,680,000 |
Existing Shares | 252,000¡Êonly O.A.¡Ë |
Shares Outstanding | PreIPO 9,879,000.00 |
PostIPO 11,559,000.00 | |
Paid Up Capital | PreIPO Y100,000,000 |
PostIPO Y642,360,700 | |
Expected Pricing Date | 2023/09/27 |
Book Building Start | 2023/09/29 |
Book Building End | 2023/10/05 |
Fix Date | 2023/10/06 |
Offering Starts | 2023/10/10 |
Offering Ends | 2023/10/13 |
Expect Pricing | Y900-Y1,040 |
Notional PER (based on previous period) |
-21.40--24.73 |
Notional PER(based on results forecast) | 50.88-58.79 |
Offering Price | Y950 |
Offering Price PER (based on previous period) |
50.88-58.79 |
Offering Price PBR (based on previous period) |
-7.74 |
Offering Price PER (based on results forecast) |
53.70 |
Use of Funds Raised |
Financial Data
Units:Y1,000
Fiscal Year End:2020/12 | ||
---|---|---|
Consolidated | Non-consolidated | |
Revenue | - | - |
Current Profit | - | -269,562 |
Net Profit | - | -271,219 |
Net Assets | - | 8,009 |
Fiscal Year End:2021/12 | ||
---|---|---|
Consolidated | Non-consolidated | |
Revenue | - | - |
Current Profit | - | -220,892 |
Net Profit | - | -228,718 |
Net Assets | - | 178,891 |
Fiscal Year End:2022/12 | ||
---|---|---|
Consolidated | Non-consolidated | |
Revenue | - | - |
Current Profit | - | -359,233 |
Net Profit | - | -392,427 |
Net Assets | - | 1,336,263 |
Recent Quarter 2023/06 |
||
---|---|---|
Consolidated | Non-consolidated | |
Revenue | - | 1,000,000 |
Current Profit | - | 651,026 |
Net Profit | - | 514,772 |
Net Assets | - | 1,851,036 |
Results Forecast 2023/12 |
||
---|---|---|
Consolidated | Non-consolidated | |
Revenue | - | 1,000,000 |
Current Profit | - | 266,000 |
Net Profit | - | 180,000 |
Net Assets | - | - |
Per Share Units:Y1
Fiscal Year End:2020/12 | ||
---|---|---|
Consolidated | Non-consolidated | |
Dividend | 0.00 | |
Net Earning | - | - |
Equity | -38.75 | -84.54 |
Fiscal Year End:2021/12 | ||
---|---|---|
Consolidated | Non-consolidated | |
Dividend | 0.00 | |
Net Earning | - | - |
Equity | -30.09 | -107.03 |
Fiscal Year End:2022/12 | ||
---|---|---|
Consolidated | Non-consolidated | |
Dividend | 0.00 | |
Net Earning | - | - |
Equity | -42.06 | -122.77 |
Fiscal Year End:Interim Results 2023/06 |
||
---|---|---|
Consolidated | Non-consolidated | |
Dividend | ||
Net Earning | - | 52.11 |
Equity | - | - |
Fiscal Year End:Results Forecast 2023/12 |
||
---|---|---|
Consolidated | Non-consolidated | |
Dividend | 0.00 | |
Net Earning | - | 17.69 |
Equity | - | - |
Comment
¢£Over allotment(252,000) |
Consolidated Subsidiaries
Name | Address |
---|
Underwriters
Allocation | Underwriter | Tel |
---|---|---|
0% | Nomura | 03-3211-1811 |
85% | SBI SECURITIES Co.,Ltd. | 03-5562-7210 |
10% | Okasan | 03-3272-2211 |
3% | SMBC Nikko | 03-5644-3111 |
1% | IwaiCosmo Securities Co.,Ltd. | 06-6229-2890 |
0.5% | Kyokuto | 03-3667-9171 |
0.3% | Matsui | 03-5216-0606 |
0.2% | Rakuten Securities | 03-6406-2681 |
Data
Date of incorporation | 2016/11/01 |
---|---|
Company address | Tokyo 106-0032 |
Telephone | 03-6629-3380 |
President | |
Homepage | https://www.kpharma.co.jp/ |
Auditor | Azsa |
Major Shareholders | |
---|---|
Shareholder Name | Ratio |
86.62% | |
22.03% | |
13.71% | |
11.59% | |
11.59% | |
10.34% | |
6.47% | |
5.88% | |
5.80% | |
4.97% | |
2.26% |
Number of Employees | 16 as of 2023/08/31 |
---|---|
Birth Date of Representative | 1960/07/30 |